Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from BioNano Genomics ( (BNGO) ) is now available.
On February 4, 2025, BioNano Genomics announced the termination of its Sales Agreement with Cowen and Company, effective February 14, 2025. This agreement, established in March 2021 and amended in March 2023, allowed the company to offer and sell up to $200 million in common stock through an ‘at the market’ equity offering program.
More about BioNano Genomics
BioNano Genomics operates in the genomics industry, focusing on providing tools and services for genome analysis.
YTD Price Performance: -66.25%
Average Trading Volume: 195,826
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $13.61M
See more data about BNGO stock on TipRanks’ Stock Analysis page.
